HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles G Eberhart Selected Research

Proteins (Proteins, Gene)

3/2022Applications of chemical exchange saturation transfer magnetic resonance imaging in identifying genetic markers in gliomas.
10/2021Mutant IDH1 promotes phagocytic function of microglia/macrophages in gliomas by downregulating ICAM1.
8/2021NGS Analysis Confirms Common TP53 and RB1 Mutations, and Suggests MYC Amplification in Ocular Adnexal Sebaceous Carcinomas.
1/2020MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid Tumors.
10/2019Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma.
5/2019ATRX Mutations in Pineal Parenchymal Tumors of Intermediate Differentiation.
1/2018Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma.
1/2018ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner.
1/2018INSM1 Expression Is Frequent in Primary Central Nervous System Neoplasms but Not in the Adult Brain Parenchyma.
2/2016Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles G Eberhart Research Topics

Disease

135Neoplasms (Cancer)
06/2022 - 03/2002
62Medulloblastoma
04/2022 - 08/2002
44Glioma (Gliomas)
06/2022 - 03/2005
33Glioblastoma (Glioblastoma Multiforme)
01/2021 - 10/2006
31Brain Neoplasms (Brain Tumor)
03/2022 - 08/2002
18Astrocytoma (Pilocytic Astrocytoma)
01/2019 - 07/2004
9Carcinogenesis
01/2016 - 09/2002
8Rhabdoid Tumor (Rhabdoid Tumors)
06/2022 - 02/2005
8Hypoxia (Hypoxemia)
04/2022 - 09/2010
8Carcinoma (Carcinomatosis)
08/2021 - 06/2006
7Uveal melanoma
06/2022 - 02/2012
6Retinoblastoma (Glioblastoma, Retinal)
06/2022 - 10/2016
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2022 - 10/2007
5Infections
06/2022 - 02/2005
5Neoplasm Metastasis (Metastasis)
05/2019 - 03/2013
4Cysts
12/2022 - 01/2013
4Melanoma (Melanoma, Malignant)
01/2022 - 08/2014
4Keratoconus
01/2020 - 05/2011
4Primitive Neuroectodermal Tumors (PNET)
01/2019 - 06/2003
4Meningioma (Meningiomas)
01/2019 - 10/2005
4Fuchs' Endothelial Dystrophy
01/2014 - 02/2010
4Alzheimer Disease (Alzheimer's Disease)
01/2014 - 09/2002
3Inflammation (Inflammations)
12/2022 - 11/2015
3Carcinoma in Situ
06/2022 - 12/2019
3Hemorrhage
03/2021 - 11/2002
3Retinal Detachment (Retinal Detachments)
01/2019 - 09/2012
3Disease Progression
01/2018 - 01/2014
3Diffuse Intrinsic Pontine Glioma
01/2017 - 06/2014
2Papilloma (Papillomatosis)
06/2022 - 12/2021
2Corneal Neovascularization
11/2020 - 01/2019
2Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2020 - 01/2019
2Pinealoma (Pineoblastoma)
05/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
03/2022 - 10/2003
20Messenger RNA (mRNA)IBA
01/2021 - 06/2003
19DNA (Deoxyribonucleic Acid)IBA
06/2022 - 02/2005
12Formaldehyde (Formol)FDA Link
06/2022 - 02/2011
12ParaffinIBA
06/2022 - 08/2010
12Biological ProductsIBA
01/2017 - 03/2004
11LigandsIBA
01/2019 - 03/2005
10RNA (Ribonucleic Acid)IBA
06/2022 - 05/2011
10MicroRNAs (MicroRNA)IBA
05/2019 - 04/2011
10Transcription Factors (Transcription Factor)IBA
01/2018 - 02/2008
9Retinaldehyde (Retinal)IBA
01/2021 - 07/2011
9Pharmaceutical PreparationsIBA
01/2021 - 01/2010
9Amyloid Precursor Protein Secretases (beta-Secretase)IBA
11/2016 - 08/2006
8Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2022 - 09/2008
8Mechanistic Target of Rapamycin Complex 1IBA
04/2022 - 12/2013
8Biomarkers (Surrogate Marker)IBA
03/2021 - 12/2008
7Small Interfering RNA (siRNA)IBA
06/2022 - 03/2005
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2021 - 09/2010
7Phosphotransferases (Kinase)IBA
01/2021 - 09/2008
7Mitogen-Activated Protein KinasesIBA
01/2021 - 01/2012
6Protons (Proton)IBA
03/2022 - 11/2013
6AmidesIBA
03/2022 - 11/2013
6Histones (Histone)IBA
05/2019 - 04/2009
6Oxygen (Dioxygen)IBA
01/2017 - 09/2010
5Temozolomide (Temodar)FDA LinkGeneric
06/2022 - 02/2013
5Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
03/2022 - 10/2013
5TOR Serine-Threonine KinasesIBA
01/2021 - 04/2005
5Telomerase (Telomerase Reverse Transcriptase)IBA
01/2019 - 06/2003
4Glutamine (L-Glutamine)FDA Link
03/2022 - 10/2019
4NucleotidesIBA
03/2022 - 10/2019
4CytokinesIBA
10/2021 - 09/2013
4Matrix Metalloproteinases (MMPs)IBA
01/2020 - 06/2006
4CateninsIBA
01/2019 - 12/2012
4ChromatinIBA
01/2018 - 12/2010
4AntigensIBA
01/2017 - 10/2003
4dipinacoline glutamateIBA
01/2017 - 09/2013
4MRK 003IBA
11/2016 - 02/2012
4Digoxin (Digitek)FDA LinkGeneric
11/2015 - 09/2010
4EnzymesIBA
11/2013 - 10/2007
4PolymersIBA
02/2013 - 11/2002
4cyclopamineIBA
12/2010 - 08/2002
3SteroidsIBA
12/2022 - 09/2012
3Glutathione (Reduced Glutathione)IBA
03/2022 - 01/2019
3Glucose (Dextrose)FDA LinkGeneric
03/2022 - 01/2017
3trametinibIBA
01/2021 - 01/2018
3Coloring Agents (Dyes)IBA
11/2017 - 08/2006
3OligonucleotidesIBA
01/2016 - 07/2007
3Lysine (L-Lysine)FDA Link
06/2014 - 04/2009
3Notch ReceptorsIBA
02/2012 - 11/2004
3beta CateninIBA
05/2004 - 09/2002
2Fluorescein (Funduscein)FDA LinkGeneric
10/2022 - 01/2021
2sapanisertibIBA
04/2022 - 03/2016
2LipidsIBA
04/2022 - 01/2022
2Glutamic Acid (Glutamate)FDA Link
03/2022 - 03/2016
2Keratins (Keratin)IBA
12/2021 - 01/2013
2Hypoxia-Inducible Factor 1IBA
03/2021 - 02/2016
2Hematoxylin (Haematoxylon)IBA
01/2021 - 01/2017
2Carboplatin (JM8)FDA LinkGeneric
01/2021 - 01/2019
2ProdrugsIBA
01/2021 - 10/2019
2Eosine Yellowish-(YS) (Eosin)IBA
01/2021 - 01/2017
2MitogensIBA
01/2020 - 02/2015
2MucinsIBA
01/2020 - 06/2018
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2020 - 02/2008
2Insulin-Like PeptidesIBA
01/2020 - 03/2011

Therapy/Procedure

44Therapeutics
10/2022 - 07/2003
14Drug Therapy (Chemotherapy)
01/2021 - 07/2004
8Radiotherapy
01/2017 - 07/2004
4Immunotherapy
12/2021 - 10/2003